Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) just unveiled an update.
Asymchem Laboratories (Tianjin) Co., Ltd. has announced its 2024 Annual General Meeting (AGM) scheduled for June 11, 2025, in Tianjin, PRC. The AGM will address several key resolutions, including the approval of the 2024 annual report, financial statements, and profit distribution plan. Additionally, the meeting will consider the re-appointment of domestic and international auditors, directors’ and supervisors’ remuneration, and the proposed foreign exchange derivatives business. Special resolutions will involve granting mandates to issue and repurchase shares, which could impact the company’s financial strategy and market positioning.
The most recent analyst rating on (HK:6821) stock is a Buy with a HK$76.45 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on providing comprehensive services for drug development and manufacturing.
Average Trading Volume: 791,381
Technical Sentiment Signal: Hold
Current Market Cap: HK$29.67B
For detailed information about 6821 stock, go to TipRanks’ Stock Analysis page.